Insider · CIK 0001319763

El Coronado Holdings, LLC

CIK 0001319763 Name as filed on the most recent filing

Filed as El Coronado Holdings, LLC (179)

341 transaction lines · from 179 filings · filed 2005-03-04 to 2014-02-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2008-08-25 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 48,902, acquired Open Form 4 filing 0000945621-08-000075
2008-07-29 P, Open-market purchase Novogen LtdNVGN 5,256,694, acquired Open Form 4 filing 0000945621-08-000063
2008-05-16 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 1,742,650, acquired Open Form 4 filing 0000943663-08-000364
2008-04-30 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 1,918,200, acquired Open Form 4 filing 0000943663-08-000316
2008-04-17 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 31,833, acquired Open Form 4 filing 0000943663-08-000284
2008-04-16 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 6,019, acquired Open Form 4 filing 0000943663-08-000284
2008-04-10 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 8,180, acquired Open Form 4 filing 0000943663-08-000272
2008-04-09 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 1,373, acquired Open Form 4 filing 0000943663-08-000272
2008-04-08 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 9,695, acquired Open Form 4 filing 0000943663-08-000270
2008-04-07 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 4,830, acquired Open Form 4 filing 0000943663-08-000270
2008-04-03 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 4,860, acquired Open Form 4 filing 0000943663-08-000262
2008-03-27 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 26,419, acquired Open Form 4 filing 0000943663-08-000251
2008-03-25 P, Open-market purchase Novogen LtdNVGN 34,279, acquired Open Form 4 filing 0000943663-08-000233
2007-11-15 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 48,795, acquired Open Form 4 filing 0000943663-07-000620
2007-11-14 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 18,443, acquired Open Form 4 filing 0000943663-07-000620
2007-11-08 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 1,640,999, acquired Open Form 4 filing 0000943663-07-000610
2007-09-10 P, Open-market purchase Novogen LtdNVGN 3,376,773, acquired Open Form 4 filing 0000943663-07-000521
2007-08-22 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 101,655, acquired Open Form 4 filing 0000943663-07-000461
2007-07-26 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 140,672, acquired Open Form 4 filing 0000943663-07-000410
2007-07-25 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 454,511, acquired Open Form 4 filing 0000943663-07-000410
2007-07-20 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 63,750, acquired Open Form 4 filing 0000943663-07-000402
2007-07-13 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2,120,580, acquired Open Form 4 filing 0000943663-07-000387
2007-07-10 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 550,406, acquired Open Form 4 filing 0000943663-07-000379
2007-07-10 P, Open-market purchase Novogen LtdNVGN 1,679,000, acquired Open Form 4 filing 0000943663-07-000381
2007-07-02 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 476,250, acquired Open Form 4 filing 0000943663-07-000362
2007-06-28 P, Open-market purchase Novogen LtdNVGN 202,440, acquired Open Form 4 filing 0000943663-07-000352
2007-06-26 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2,875,000, acquired Open Form 4 filing 0000943663-07-000341
2007-06-22 P, Open-market purchase Novogen LtdNVGN 60,182, acquired Open Form 4 filing 0000943663-07-000304
2007-06-21 P, Open-market purchase Novogen LtdNVGN 35,458, acquired Open Form 4 filing 0000943663-07-000300
2007-06-20 P, Open-market purchase Novogen LtdNVGN 125,074, acquired Open Form 4 filing 0000943663-07-000300
2007-06-19 P, Open-market purchase Novogen LtdNVGN 91,452, acquired Open Form 4 filing 0000943663-07-000296
2007-06-18 P, Open-market purchase Novogen LtdNVGN 13,986, acquired Open Form 4 filing 0000943663-07-000296
2007-06-15 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 55,384, acquired Open Form 4 filing 0000943663-07-000292
2007-06-14 P, Open-market purchase Novogen LtdNVGN 7 lines 47,907, acquired Open Form 4 filing 0000943663-07-000294
2007-06-14 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 45,661, acquired Open Form 4 filing 0000943663-07-000292
2007-06-13 P, Open-market purchase Novogen LtdNVGN 89,324, acquired Open Form 4 filing 0000943663-07-000290
2007-06-13 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 19,408, acquired Open Form 4 filing 0000943663-07-000288
2007-06-12 P, Open-market purchase Novogen LtdNVGN 23,414, acquired Open Form 4 filing 0000943663-07-000290
2007-06-12 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 41,654, acquired Open Form 4 filing 0000943663-07-000288
2007-06-08 P, Open-market purchase Novogen LtdNVGN 74,818, acquired Open Form 4 filing 0000943663-07-000281
2007-06-08 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 22,034, acquired Open Form 4 filing 0000943663-07-000279
2007-06-07 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 13,532, acquired Open Form 4 filing 0000943663-07-000273
2007-06-07 P, Open-market purchase Novogen LtdNVGN 9,241, acquired Open Form 4 filing 0000943663-07-000275
2007-06-06 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2,540, acquired Open Form 4 filing 0000943663-07-000273

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. El Coronado Holdings, LLC, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001319763

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.